Skip to main content
    B

    BioAge Labs, Inc (BIOA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $5.10
    -0.12 (-2.30%)

    Market Cap: $239.87M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    BioAge Labs, Inc (BIOA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    BioAge Labs (BIOA) has a latest price of $5.10 on Nov 17, 2026, 80.3% below its 52-week high of $25.95. Its price fell 34.6% over the past 12 months.

    Price Chart

    From Sep 2024 to Oct 2026, its highest month-end close was $24.51 in Jun 2026 and its lowest $3.76 in Mar 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart BIOA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BIOA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 52.6%, and over 6 months it fell 68.8%.

    PeriodChange
    1 month+2.2%
    3 months-52.6%
    6 months-68.8%
    12 months-34.6%
    12 months, with dividends-34.6%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$5.87-55.6%
    2025$13.23+128.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 20.6% below its 50-day average of $6.43 and 65.9% below its 200-day average of $14.97.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$5.10
    52-week high$25.95-80.3%
    52-week low$4.81+6.0%
    50-day average$6.43-20.6%
    200-day average$14.97-65.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 88.2%.

    MeasureValue
    1-year beta1.70
    Largest fall, 1 year-80.7%
    Largest fall, 3 years-88.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About BIOA

    What is BIOA's 1-year price change?

    BioAge Labs's price fell 34.6% over the past 12 months. With dividends included, the 12-month total return was -34.6%.

    What is BIOA's 52-week high and low?

    BioAge Labs's 52-week high is $25.95 and its 52-week low is $4.81. Its latest price of $5.10 on Nov 17, 2026 is 80.3% below the high.

    What is BIOA's beta?

    BioAge Labs's 1-year beta against the S&P 500 is 1.70, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 80.7%.

    Is the BIOA chart free?

    Yes. Advanced Charting for BIOA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.